Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timolol vs Brinzolamide added to Travoprost in Glaucoma/OHT
NCT00372827Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Feb 2004
- Primary completion
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of brinzolamide in primary open-angle glaucoma (POAG), ocular hypertension and pigmentary glaucoma (PG) (2 arms), sponsored by Alcon Inc. Primary endpoint: Mean Diurnal Intraocular Pressure at 3 months. Started Feb 2004; status: completed.
02
Drugs
brinzolamide
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertensionpigmentary glaucoma (PG)
Beyond the preview
Go deeper on NCT00372827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00372827.